Roca I,Akova M,Baquero F,Carlet J,Cavaleri M .2015 .The global threat of antimicrobial resistance: science for intervention. New Microbes and New Infections, 6 : 22-29.
Mancuso G,Midiri A,Gerace E,Biondo C .2021 .Bacterial Antibiotic Resistance: The Most Critical Pathogens. , 10(10) : 1310.
Larsson DGJ,Flach CF .2022 .Antibiotic resistance in the environment. Nature Reviews Microbiology, 20(5) : 257-269.
Shakil S,Rizvi SMD,Greig NH .2021 .High Throughput Virtual Screening and Molecular Dynamics Simulation for Identifying a Putative Inhibitor of Bacterial CTX-M-15. , 10(5) : 474.
Yasir M,Ajlan AM,Shakil S,Jiman-Fatani AA,Almasaudi SB .2018 .Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum beta-lactamaseproducing Escherichia coli in western Saudi Arabia. Scientific Reports, 8(1) : 14847.
Bush K,Courvalin P,Dantas G,Davies J,Eisenstein B .2011 .Tackling antibiotic resistance. Nature Reviews Microbiology, 9(12) : 894-896.
Bush K,Bradford PA .2020 .Epidemiology of beta-LactamaseProducing Pathogens. Clinical Microbiology Reviews, 33(2) : e00047-19.
Peirano G,Pitout JDD,Extended-Spectrum JDD .2019 .. Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options. Drugs, 79(14) : 1529-1541.
Smet A,Martel A,Persoons D,Dewulf J,Heyndrickx M .2010 .Broad-spectrum beta-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiology Reviews, 34(3) : 295-316.
Bevan ER,Jones AM,Hawkey PM .2017 .Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype. Journal of Antimicrobial Chemotherapy, 72(8) : 2145-2155.
Quinones D,Aung MS,Carmona Y,Gonzalez MK,Pereda N .2020 .High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba. , 9(1) : 65.
Mwangi J,Hao X,Lai R,Zhang ZY .2019 .Antimicrobial peptides: new hope in the war against multidrug resistance. Zoological Research, 40(6) : 488-505.
Sabe VT,Ntombela T,Jhamba LA,Maguire GEM,Govender T .2021 .Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. European Journal of Medicinal Chemistry, 224 : 113705.
Giordano D,Biancaniello C,Argenio MA,Facchiano A .2022 .Drug Design by Pharmacophore and Virtual Screening Approach. , 15(5) : 646.
Reddy AS,Pati SP,Kumar PP,Pradeep HN,Sastry GN .2007 .Virtual screening in drug discovery -- a computational perspective. Current Protein & Peptide Science, 8(4) : 329-351.
Cavasotto CN,Orry AJ .2007 .Ligand docking and structure-based virtual screening in drug discovery. Current Topics in Medicinal Chemistry, 7(10) : 1006-1014.
Good AC,Cheney DL .2003 .Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques. Journal of Molecular Graphics and Modelling, 22(1) : 23-30.
Irwin JJ,Shoichet BK .2005 .-a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1) : 177-182.
Dallakyan S,Olson AJ .2015 .Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263 : 243-250.
Daina A,Michielin O,Zoete V. .2017 .SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7 : 42717.
Drawz SM,Papp-Wallace KM,Bonomo RA .2014 .New betalactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrobial Agents and Chemotherapy, 58(4) : 1835-1846.
Pinzi L,Rastelli G.,Molecular G. .2019 .Docking: Shifting Paradigms in Drug Discovery. International Journal of Molecular Sciences, 20(18) : 4331.
Gupta M,Sharma R,Kumar A .2018 .Docking techniques in pharmacology: How much promising? Computational Biology. , 76 : 210-217.
Meng XY,Zhang HX,Mezei M,Cui M.,Computer-Aided Drug Design .2011 .Molecular docking: a powerful approach for structure-based drug discovery. , 7(2) : 146-157.
Sait KHW,Mashraqi M,Khogeer AA,Alzahrani O,Anfinan NM .2020 .Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents. Bioinformation, 16(11) : 882-887.
Sait KHW,Alam Q,Anfinan N,Al-Ghamdi O,Malik A .2019 .Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer. Bioinformation, 15(4) : 287-294.
Faheem M,Rehman MT,Danishuddin M,Khan AU .2013 .; 8(2): e56926.. PLoS One, : .
Lahiri SD,Mangani S,Durand-Reville T,Benvenuti M,De Luca F M .2013 .Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC beta-lactamases. Antimicrobial Agents and Chemotherapy, 57(6) : 2496-2505.
.2015 .Molecular Mechanism of Avibactam-Mediated betaLactamase Inhibition. ACS Infectious Diseases, 1(4) : 175-184.
Agents Antimicrobial .2015 .. , 59(7) : 3700-3709.
Larregieu CA,Benet LZ .2013 .(. The AAPS Journal, 15(2) : 483-497.
Rossiter SE,Fletcher MH,Wuest WM .2017 .Natural Products as Platforms To Overcome Antibiotic Resistance. Chemical Reviews, 117(19) : 12415-12474.
Newman DJ,Cragg GM .2020 .Natural Products as Sources of New Drugs over the Nearly Four Decades from. , 83(3) : 770-803.
Mayegowda SB,Ng M,Alghamdi S,Atwah B,Alhindi Z .2022 .To read the copy of this license please visit: https://creativecommons. Evidence-Based Complementary and Alternative Medicine, : 2500613.